Tissue-print and print-phoresis as platform technologies for the molecular analysis of human surgical specimens: mapping tumor invasion of the prostate capsule

被引:21
作者
Gaston, SM
Soares, MA
Siddiqui, MM
Vu, D
Lee, JM
Goldner, DL
Brice, MJ
Shih, JC
Upton, MP
Perides, G
Baptista, J
Lavin, PT
Bloch, BN
Genega, EM
Rubin, MA
Lenkinski, RE
机构
[1] Beth Israel Deaconess Med Ctr, Dept Surg, Div Urol, Boston, MA 02215 USA
[2] Harvard Univ, Sch Med, Boston, MA 02115 USA
[3] Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA
[4] Tufts Univ New England Med Ctr, Dept Surg, Boston, MA 02111 USA
[5] Averion Biostat, Framingham, MA 01701 USA
[6] Beth Israel Deaconess Med Ctr, Dept Radiol, Boston, MA 02215 USA
[7] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA
关键词
D O I
10.1038/nm1169
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Molecular profiling of human biopsies and surgical specimens is frequently complicated by their inherent biological heterogeneity and by the need to conserve tissue for clinical diagnosis. We have developed a set of novel 'tissue print' and 'print-phoresis' technologies to facilitate tissue and tumor-marker profiling under these circumstances. Tissue printing transfers cells and extracellular matrix components from a tissue surface onto nitrocellulose membranes, generating a two-dimensional anatomical image on which molecular markers can be visualized by specific protein and RNA- and DNA-detection techniques. Print-phoresis is a complementary new electrophoresis method in which thin strips from the print are subjected to polyacrylamide gel electrophoresis, providing a straightforward interface between the tissue-print image and gel-based proteomic techniques. Here we have utilized these technologies to identify and characterize markers of tumor invasion of the prostate capsule, an event generally not apparent to the naked eye that may result in tumor at the surgical margins ('positive margins'). We have also shown that tissue-print technologies can provide a general platform for the generation of marker maps that can be superimposed directly onto histopathological and radiological images, permitting molecular identification and classification of individual malignant lesions.
引用
收藏
页码:95 / 101
页数:7
相关论文
共 31 条
[1]   Type XXIII collagen, a new transmembrane collagen identified in metastatic tumor cells [J].
Banyard, J ;
Bao, L ;
Zetter, BR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (23) :20989-20994
[2]   Changes in collagen metabolism in prostate cancer: A host response that may alter progression [J].
Burns-Cox, N ;
Avery, NC ;
Gingell, JC ;
Bailey, AJ .
JOURNAL OF UROLOGY, 2001, 166 (05) :1698-1701
[3]   Molecular mechanisms of tumor invasion and metastasis: An integrated view [J].
Cairns, RA ;
Khokha, R ;
Hill, RP .
CURRENT MOLECULAR MEDICINE, 2003, 3 (07) :659-671
[4]   Proteomics in translational cancer research: Toward an integrated approach [J].
Celis, JE ;
Gromov, P .
CANCER CELL, 2003, 3 (01) :9-15
[5]   Does increased needle biopsy sampling of the prostate detect a higher number of potentially insignificant tumors? [J].
Chan, TY ;
Chan, DY ;
Lecksell, K ;
Stutzman, RE ;
Epstein, JI .
JOURNAL OF UROLOGY, 2001, 166 (06) :2181-2184
[6]   Delineation of prognostic biomarkers in prostate cancer [J].
Dhanasekaran, SM ;
Barrette, TR ;
Ghosh, D ;
Shah, R ;
Varambally, S ;
Kurachi, K ;
Pienta, KJ ;
Rubin, MA ;
Chinnaiyan, AM .
NATURE, 2001, 412 (6849) :822-826
[7]   Molecular profiling of clinical tissue specimens - Feasibility and applications [J].
Emmert-Buck, MR ;
Strausberg, RL ;
Krizman, DB ;
Bonaldo, MF ;
Bonner, RF ;
Bostwick, DG ;
Brown, MR ;
Buetow, KH ;
Chuaqui, RF ;
Cole, KA ;
Duray, PH ;
Englert, CR ;
Gillespie, JW ;
Greenhut, S ;
Grouse, L ;
Hillier, LW ;
Katz, KS ;
Klausner, RD ;
Kuznetzov, V ;
Lash, AE ;
Lennon, G ;
Linehan, WM ;
Liotta, LA ;
Marra, MA ;
Munson, PJ ;
Ornstein, DK ;
Prabhu, VV ;
Prange, C ;
Schuler, GD ;
Soares, MB ;
Tolstoshev, CM ;
Vocke, CD ;
Waterston, RH .
JOURNAL OF MOLECULAR DIAGNOSTICS, 2000, 2 (02) :60-66
[8]   Decrease and gain of gene expression are equally discriminatory markers for prostate carcinoma -: A gene expression analysis on total and microdissected prostate tissue [J].
Ernst, T ;
Hergenhahn, M ;
Kenzelmann, M ;
Cohen, CD ;
Bonrouhi, M ;
Weninger, A ;
Klären, R ;
Gröne, EF ;
Wiesel, M ;
Güdemann, C ;
Küster, J ;
Schott, W ;
Staehler, G ;
Kretzler, M ;
Hollstein, M ;
Gröne, HJ .
AMERICAN JOURNAL OF PATHOLOGY, 2002, 160 (06) :2169-2180
[9]  
Friedberg MH, 1998, CANCER, V82, P923, DOI 10.1002/(SICI)1097-0142(19980301)82:5<923::AID-CNCR18>3.0.CO
[10]  
2-2